GE HealthCare executive resigns; insider files notice of proposed share sale
On November 4, 2026, Taha Kass-Hout, chief science and technology officer at GE HealthCare Technologies Inc., announced his resignation. The same day, former officer James Saccaro filed a notice of a proposed sale of 78,348 shares.
Key points
- Taha Kass-Hout notified the company of his intention to resign as chief science and technology officer on November 4, 2026.
- James Saccaro filed a Form 144, a notice of a proposed sale, for 78,348 shares of GE HealthCare Technologies Inc. This is a notification of a proposed transaction and not a confirmation of a completed sale.
Leadership changes and insider plans
Taha Kass-Hout notified the company of his intention to resign as chief science and technology officer on November 4, 2026.
Former officer James Saccaro filed a notice to sell 78,348 shares. The filing indicates the shares were related to the exercise of options for 54,472 and 23,876 shares on the same day.
Notice of proposed sale
James Saccaro filed a Form 144, a notice of a proposed sale, for 78,348 shares of GE HealthCare Technologies Inc. This is a notification of a proposed transaction and not a confirmation of a completed sale.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow GE HealthCare Technologies
A notification in your browser or on your phone when we publish about GE HealthCare Technologies. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
